Cargando…

Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer

INTRODUCTION: Corticosteroids are used to treat immune-related adverse events (irAEs) associated with nivolumab. However, patients with non-small-cell lung cancer who are administered corticosteroids before the initiation of nivolumab treatment are commonly excluded from clinical trials. The appropr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umehara, Kengo, Yama, Kaori, Goto, Keisuke, Wakamoto, Azusa, Hatsuyama, Tae, Honjo, Osamu, Saikai, Toyohiro, Fujita, Akihisa, Sato, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204518/ https://www.ncbi.nlm.nih.gov/pubmed/33733906 http://dx.doi.org/10.1177/1073274820985790

Ejemplares similares

Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib
por: Hayashi, Nobuyoshi, et al.
Publicado: (2017)

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
por: Kanai, Osamu, et al.
Publicado: (2018)

Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin’s Lymphoma on DeVIC Therapy
por: Umehara, Kengo, et al.
Publicado: (2023)

Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer
por: Takada, Shinya, et al.
Publicado: (2022)

Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature
por: Matsuo, Keisuke, et al.
Publicado: (2019)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
por: Imakita, Takuma, et al.
Publicado: (2017)

Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug
por: Seita, Akihisa, et al.
Publicado: (2021)

Impressive response to nivolumab of non‐small‐cell lung cancer containing sarcomatoid components
por: Ota, Takahiro, et al.
Publicado: (2019)

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer
por: Hida, Toyoaki, et al.
Publicado: (2017)

Concurrence of nivolumab‐induced interstitial lung disease and cancer invasion
por: Kanai, Osamu, et al.
Publicado: (2017)

Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation()
por: Sato, Keisuke, et al.
Publicado: (2013)

Glycolaldehyde induces endoplasmic reticulum stress and apoptosis in Schwann cells
por: Sato, Keisuke, et al.
Publicado: (2015)

Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab
por: Sakaguchi, Hiroyuki, et al.
Publicado: (2021)

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
por: Narukawa, Tsukasa, et al.
Publicado: (2020)

Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
por: Yama, Kaori, et al.
Publicado: (2014)

Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab
por: Funazo, Tomoko Yamamoto, et al.
Publicado: (2019)

No need to hesitate: immune‐related neutropenia and thrombocytopenia that improved by corticosteroids
por: Kanai, Osamu, et al.
Publicado: (2021)

Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series
por: Hashimoto, Kentaro, et al.
Publicado: (2022)

Safety of Epidural Corticosteroid Injections
por: Pountos, Ippokratis, et al.
Publicado: (2015)

Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report
por: Honjo, Osamu, et al.
Publicado: (2019)

CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer
por: Ogimoto, Tatsuya, et al.
Publicado: (2023)

Efficacy and safety of nivolumab for metastatic biliary tract cancer
por: Gou, Miaomiao, et al.
Publicado: (2019)

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
por: Janjigian, Yelena Y., et al.
Publicado: (2018)

Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis
por: Yang, Yi, et al.
Publicado: (2020)

A Case of IgA Vasculitis During Nivolumab Therapy for Renal Cell Carcinoma
por: Nagaoka-Takatori, Asami, et al.
Publicado: (2021)

Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer
por: Kanda, Shintaro, et al.
Publicado: (2020)

Myasthenic crisis and polymyositis induced by one dose of nivolumab
por: Kimura, Toshihiro, et al.
Publicado: (2016)

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
por: Nomizo, Takashi, et al.
Publicado: (2017)

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
por: Niwa, Kazutomo, et al.
Publicado: (2020)

History-dependent physiological adaptation to lethal genetic modification under antibiotic exposure
por: Koganezawa, Yuta, et al.
Publicado: (2022)

Detecting Photoactivatable Cre-mediated Gene Deletion Efficiency in Escherichia coli
por: Koganezawa, Yuta, et al.
Publicado: (2023)

Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer
por: Iikura, Yusuke, et al.
Publicado: (2022)

Safety of intranasal corticosteroids in acute rhinosinusitis
por: Demoly, Pascal
Publicado: (2008)

Temperature Dependence on Tensile Mechanical Properties of Sintered Silver Film
por: Wakamoto, Keisuke, et al.
Publicado: (2020)

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
por: Lepik, Kirill V., et al.
Publicado: (2020)

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
por: Fedorova, Liudmila V., et al.
Publicado: (2021)

Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
por: Pluchart, Hélène, et al.
Publicado: (2017)

Severe Gastritis after Administration of Nivolumab and Ipilimumab
por: Nishimura, Yoshito, et al.
Publicado: (2018)

Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy
por: Mizutani, Kosuke, et al.
Publicado: (2018)

Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer
por: Takada, Kenji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oqdqrjfeu054dcog9vl6g8qn2m